全文获取类型
收费全文 | 341550篇 |
免费 | 38519篇 |
国内免费 | 2799篇 |
专业分类
耳鼻咽喉 | 8430篇 |
儿科学 | 12015篇 |
妇产科学 | 7048篇 |
基础医学 | 30783篇 |
口腔科学 | 7022篇 |
临床医学 | 41079篇 |
内科学 | 82029篇 |
皮肤病学 | 12714篇 |
神经病学 | 32439篇 |
特种医学 | 16136篇 |
外国民族医学 | 25篇 |
外科学 | 72100篇 |
综合类 | 1409篇 |
现状与发展 | 72篇 |
一般理论 | 46篇 |
预防医学 | 16024篇 |
眼科学 | 8210篇 |
药学 | 14041篇 |
中国医学 | 417篇 |
肿瘤学 | 20829篇 |
出版年
2023年 | 5561篇 |
2022年 | 2032篇 |
2021年 | 4884篇 |
2020年 | 7398篇 |
2019年 | 3948篇 |
2018年 | 10573篇 |
2017年 | 9938篇 |
2016年 | 12043篇 |
2015年 | 12414篇 |
2014年 | 19892篇 |
2013年 | 21730篇 |
2012年 | 15140篇 |
2011年 | 14532篇 |
2010年 | 15691篇 |
2009年 | 18730篇 |
2008年 | 14558篇 |
2007年 | 13777篇 |
2006年 | 16099篇 |
2005年 | 13739篇 |
2004年 | 12488篇 |
2003年 | 11358篇 |
2002年 | 11259篇 |
2001年 | 10425篇 |
2000年 | 9609篇 |
1999年 | 9040篇 |
1998年 | 5560篇 |
1997年 | 5035篇 |
1996年 | 4559篇 |
1995年 | 4179篇 |
1994年 | 2840篇 |
1993年 | 2385篇 |
1992年 | 4000篇 |
1991年 | 3918篇 |
1990年 | 3537篇 |
1989年 | 3475篇 |
1988年 | 3044篇 |
1987年 | 2839篇 |
1986年 | 2746篇 |
1985年 | 2518篇 |
1984年 | 1960篇 |
1983年 | 1660篇 |
1982年 | 1289篇 |
1979年 | 1796篇 |
1978年 | 1428篇 |
1977年 | 1319篇 |
1975年 | 1408篇 |
1974年 | 1387篇 |
1973年 | 1293篇 |
1972年 | 1371篇 |
1971年 | 1239篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
S Chinn S H Downs J M Anto M W Gerbase B Leynaert R de Marco C Janson D Jarvis N Künzli J Sunyer C Svanes E Zemp U Ackermann-Liebrich P Burney 《The European respiratory journal》2006,28(4):763-771
The incidence of asthma has been reported to be associated with obesity. An alternative analysis, of net change in prevalence, does not require exclusion of those with asthma at baseline. Follow-up data were obtained from 9,552 participants in the European Community Respiratory Health Survey and the Swiss cohort Study on Air Pollution and Lung Disease in Adults. Incidence of asthma was analysed by proportional hazards regression, and net changes in symptoms and asthma status by generalised estimating equations, by obesity group. Incidence and net change in ever having had asthma were greater in females than in males, and in participants who remained obese compared with those who were never obese (hazard ratio 2.00, 95% confidence interval 1.25-3.20; excess net change 2.8%, 0.4-5.3% per 10 yrs). The effect of being obese on net change in diagnosed asthma was greater in females than in males, but for net change in wheeze without a cold it was greater in males. The present results are consistent with asthma being more frequently diagnosed in females, especially obese females. These findings may help to explain the reports of a stronger association between asthma and obesity in females than in males. 相似文献
64.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献
65.
66.
67.
68.
Adalberto Parra Jorge Ramírez-Peredo Rocío Hidalgo Amelia Morales-Toquero Gabriela Velásquez-Ramírez Alejandro Ruiz-Argüelles Guillermo J Ruiz-Argüelles 《Biology of blood and marrow transplantation》2006,12(5):566-572
We compared the functional status of the hypothalamic dopaminergic tone in patients given an allogeneic hematopoietic stem cell transplantation (allo-HSCT) with chronic graft-versus-host disease (GVHD) with that observed in patients with allo-HSCT without chronic GVHD and in healthy controls. The effect of acute dopaminergic blockade with intravenous metoclopramide on serum prolactin (PRL) concentrations was evaluated. Twenty volunteers, 20 to 52 years of age, seronegative for both hepatitis C virus and the human immunodeficiency virus, were studied: (1) 10 clinically healthy men (group 1), and (2) 9 patients with leukemia, and 1 patient with refractory aplastic anemia who underwent allo-HSCT, 5 of whom (3 men and 2 women) developed chronic GVHD (group 2), and 5 (3 men and 2 women) who did not develop chronic GVHD (group 3). Serum PRL concentrations were measured both fasting and after intravenous administration of metoclopramide (10-mg bolus). The area under the PRL curve was calculated. Patients in group 2 were older than those in groups 1 and 3 (P<.018), but their body mass index was similar. Fasting serum PRL concentrations were similar among the 3 groups; however, group 2 had higher PRL concentrations throughout the test (P<.001) and a greater area under the PRL curve than groups 1 and 3 (P<.001), without differences between the last 2 groups. The differences remained significant after adjustment for age (P<.01). Our results in a small group of patients with chronic GVHD after allo-HSCT suggest the existence of an increased functional level of their hypothalamic dopamine tone, which would favor a tendency toward a diminished endogenous production, release of pituitary PRL, or both. This could represent an adaptive mechanism aiming to maintain circulating PRL concentrations within a physiological range. 相似文献
69.
Yaprak Engin-Ustün Yusuf Ustün M Mutlu Meydanli Ay?e Kafkasli 《Gynecological endocrinology》2006,22(12):676-679
AIM: To compare the effects of 17beta-estradiol given intranasally (intranasal E2) and raloxifene on serum lipid profile and fibrinogen in hypercholesterolemic postmenopausal women. METHODS: The study population consisted of 46 women after menopause. The placebo group (n = 11) was given calcium, while the intervention groups were given intranasal E2 (Aerodiol; Servier, Chambray-les-Tours, France) (n = 16) or raloxifene (Evista; Lilly SA, Madrid, Spain) (n = 19). Blood lipids and fibrinogen were compared between groups at baseline and after 3 months of treatment. RESULTS: The group receiving intranasal E2 showed a significant decrease in triglyceride levels (p<0.05) and a marked increase in high-density lipoprotein cholesterol levels (p<0.05). No changes in lipid profile were observed in the raloxifene and placebo groups. Raloxifene caused a significant decrease in fibrinogen levels (p<0.05). CONCLUSION: Intranasal E2 exerts significant effects on lipid profile in hypercholesterolemic postmenopausal women. Raloxifene has a greater impact on fibrinogen than intranasal E2 application. 相似文献
70.